Drug Interactions between Adempas and Lorabid Pulvules
This report displays the potential drug interactions for the following 2 drugs:
- Adempas (riociguat)
- Lorabid Pulvules (loracarbef)
Interactions between your drugs
No interactions were found between Adempas and Lorabid Pulvules. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Adempas
A total of 351 drugs are known to interact with Adempas.
- Adempas is in the drug class vasodilators.
- Adempas is used to treat Pulmonary Arterial Hypertension.
Lorabid Pulvules
A total of 46 drugs are known to interact with Lorabid Pulvules.
- Lorabid pulvules is in the drug class second generation cephalosporins.
- Lorabid pulvules is used to treat the following conditions:
Drug and food interactions
loracarbef food
Applies to: Lorabid Pulvules (loracarbef)
You may experience reduced absorption of loracarbef in the presence of food. Take loracarbef on an empty stomach 1 hour before or 2 hours after a meal. This will make it easier for your body to absorb the medication.
riociguat food
Applies to: Adempas (riociguat)
Chemical substances present in cigarette smoke may reduce the blood levels of riociguat. This means that the medication may be less effective if you smoke during treatment. Let your doctor know if you are a smoker, or if you start smoking or stop smoking during treatment with riociguat, because the dosage may need to be adjusted. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Food may affect the absorption and blood levels of riociguat. To avoid significant fluctuations in blood levels of the medication, riociguat should be taken about the same time each day consistently either with or without food.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.